Oct 3, 2023

FendX Successfully Completes Pilot Run to Manufacture REPELWRAP™ Film using Dunmore’s Commercial Equipment

Welcome aboard! Your submission has been received and you are now a member of the MedicalGold.ca community.
Oops! Something went wrong while submitting the form. Please check the format of your entry.
Subscribe to Excellence

Oakville, Ontario, October 3, 2023FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the "Company" or "FendX"), a nanotechnology company developing surface protection coatings to reduce the spread of pathogens, is pleased to announce that the Company has successfully completed a pilot manufacturing run on Dunmore International Corp.’s (“Dunmore”) commercial manufacturing line and completed its intermediate scale-up objective to demonstrate the REPELWRAP™ film formulation can be scaled-up and is suitable for automated manufacturing.

  • Over 5,000 feet of REPELWRAP™ film was produced using Dunmore's commercial manufacturing line.
  • Film production time took minutes on Dunmore equipment compared to approximately 24 hours to produce the original lab prototype.
  • Film produced met expected repelling properties.
“Successful automation of the film production process is a huge testament to our ability to advance our nanotechnology in collaboration with Dunmore and McMaster University. “Scaling-up the postage stamp-size lab prototype film that originally took approximately 24 hours to produce in McMaster’s lab to successfully producing sheets of nano-coated film within minutes from the pilot run conducted at Dunmore is a considerable undertaking that we are very pleased to have achieved.”
~ Dr. Carolyn Myers, CEO of FendX

The pilot run on Dunmore’s manufacturing line involved the continuous processing of a roll of plastic (approximately 5,800 feet in length) that was conveyed along a roller-based line. The output resulted in production of sheets of film covered with the Company’s nanotechnology confirming the REPELWRAP™ film formulation was successfully coated onto the plastic and is suitable for automated manufacturing.  Samples of the film were tested by McMaster and were confirmed to have repelling properties similar to the McMaster lab prototype film. With this achievement, the Company has demonstrated successful scale-up of the original lab prototype, the size of a postage stamp, to creating sheets of REPELWRAP™ film on Dunmore’s commercial manufacturing line. These positive findings allow the Company to advance to further refinement of the films and conduct further testing, including real world conditions testing. Automation of the manufacturing process is a key step in leading to the production of a commercial product.

“We are pleased to have automated the manufacturing process for the adapted formula of REPELWRAP™ film in pilot runs on our commercial manufacturing line. “These successful pilot manufacturing runs confirm we can produce intermediate size films and we look forward to working with FendX on further refinement using our production processes.”
~ Nik Taritas, Vice President of Business Development at Dunmore

The Company entered into a development stage agreement with Dunmore, a Steel Partners Holdings L.P. (NYSE: SPLP) operating company to assess scale-up of REPELWRAP™ film, as previously announced on April 12, 2023. On June 22, 2023, the Company announced they had successfully completed the first phase of the work to adapt McMaster University’s lab prototype formula to Dunmore’s manufacturing process.  The second phase of the work was to conduct automated pilot runs on Dunmore’s commercial manufacturing equipment.

About REPELWRAP™ film

REPELWRAP™ film is the Company's first product under development and is a protective surface coating film that leverages the Company's award-winning nanotechnology. REPELWRAP™ film has demonstrated unique repelling properties that prevent the adhesion of pathogens, bacteria, and viruses, reducing their transmission on surfaces prone to contamination. The Company believes REPELWRAP™ film will have applications in healthcare settings and other industries.

About Dunmore International Corp.

Dunmore is a global manufacturer of engineered coated and laminated films and foils with manufacturing facilities in the U.S. and Germany. Dunmore offers film conversion services such as coating, metallizing, and laminating along with contract film manufacturing and custom film product development. Dunmore services a diverse group of industries including aircraft, spacecraft, photovoltaic, graphic arts & labels, packaging, and insulation. Dunmore is a subsidiary of Steel Partners and is ISO 9001:2015 and OSHA VPP Star certified.

About FendX Technologies Inc.

FendX is a Canada-based nanotechnology company focused on developing products to make people's lives safer by reducing the spread of pathogens. The Company is developing both film and spray products to protect surfaces from contamination. The lead product under development, REPELWRAP™ film, is a protective surface coating film that, due to its repelling properties, prevents the adhesion of pathogens and reduces their transmission on surfaces prone to contamination. The spray nanotechnology is a bifunctional spray coating being developed to reduce contamination on surfaces by repelling and killing pathogens. The Company is conducting research and development activities using its nanotechnology in collaboration with industry-leading partners, including McMaster University. The Company has an exclusive worldwide license to its technology and IP portfolio from McMaster, which encompass both film and spray coating nanotechnology formulations.


“Carolyn Myers”

Carolyn Myers

Chief Executive Officer and Director


Dr. Carolyn Myers, CEO and Director


Alyssa Barry, Investor Relations




The work included in this article is based on current events, technical charts, company news releases, and the author’s opinions. It may contain errors, and you shouldn’t make any investment decision based solely on what you read here. This publication contains forward-looking statements, including but not limited to comments regarding predictions and projections. Forward-looking statements address future events and conditions and therefore involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated in such statements. This publication is provided for informational and entertainment purposes only and is not a recommendation to buy or sell any security. Always thoroughly do your own due diligence and talk to a licensed investment adviser prior to making any investment decisions. Junior resource and biotechnology companies can easily lose 100% of their value so read company profiles on www.SEDARplus.ca for important risk disclosures. It’s your money and your responsibility.

Other News

See All News

Other Articles

See All Articles